Literature DB >> 20096013

Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant.

Katherine A Hale1, Peter J Shaw, Luciano Dalla-Pozza, Chandini Raina MacIntyre, David Isaacs, Tania C Sorrell.   

Abstract

Patients aged 0-18 years with confirmed or possible invasive fungal infection were identified by medical record and database searches. Cases with an underlying diagnosis of acute leukaemia or following stem cell transplantation were included in a case control study. Controls included all other children with acute leukaemia or stem cell transplant in the corresponding time period. Variables collected included demographics, underlying disease risk and status, organ impairment, admission to intensive care unit, fungal infection details and certain transplant variables. Risk factors for development of invasive fungal infection were examined using logistic regression. There were 106 cases of invasive fungal infection during the study. The incidence of invasive fungal infection was 21% in acute lymphoblastic leukaemia, 15% in acute myeloid leukaemia and 25% following stem cell transplantation. Sixty per cent were neutropenic at diagnosis and 39% had concomitant bacteremia. High risk acute lymphoblastic leukaemia, relapsed disease, intensive care admission and graft-versus-host disease were significantly associated with development of invasive fungal infection on multivariate analysis. These associations provide new information on paediatric invasive fungal infections and warrant further study; caution should be encouraged when extrapolating from adult studies.

Entities:  

Mesh:

Year:  2010        PMID: 20096013     DOI: 10.1111/j.1365-2141.2009.08072.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

1.  Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study.

Authors:  J M Lestner; A Versporten; K Doerholt; A Warris; E Roilides; M Sharland; J Bielicki; H Goossens
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

2.  Impact of the D-index deduced from duration and intensity of neutropenia following chemotherapy on the risk of invasive fungal infection in pediatric acute myeloid leukemia.

Authors:  Hirozumi Sano; Ryoji Kobayashi; Daisuke Suzuki; Daiki Hori; Kenji Kishimoto; Kunihiko Kobayashi
Journal:  Int J Hematol       Date:  2018-03-21       Impact factor: 2.490

3.  Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.

Authors:  Michaela Döring; Karin Melanie Cabanillas Stanchi; Manon Queudeville; Judith Feucht; Franziska Blaeschke; Patrick Schlegel; Tobias Feuchtinger; Peter Lang; Ingo Müller; Rupert Handgretinger; Werner J Heinz
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-03       Impact factor: 4.553

Review 4.  Fungal infections in children with haematologic malignancies and stem cell transplant recipients.

Authors:  William R Otto; Abby M Green
Journal:  Br J Haematol       Date:  2020-03-11       Impact factor: 6.998

5.  Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.

Authors:  Seth E Karol; Thomas B Alexander; Amit Budhraja; Stanley B Pounds; Kristin Canavera; Lei Wang; Joshua Wolf; Jeffery M Klco; Paul E Mead; Soumyasri Das Gupta; Su Y Kim; Ahmed Hamed Salem; Tammy Palenski; Norman J Lacayo; Ching-Hon Pui; Joseph T Opferman; Jeffrey E Rubnitz
Journal:  Lancet Oncol       Date:  2020-03-11       Impact factor: 41.316

Review 6.  Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.

Authors:  Athanasios Tragiannidis; Charalampos Dokos; Thomas Lehrnbecher; Andreas H Groll
Journal:  Drugs       Date:  2012-03-26       Impact factor: 11.431

7.  Current evidence of antifungal prophylaxis and therapy in pediatric patients.

Authors:  Mareva Giacchino; Giuseppe Maria Milano; Francesca Carraro; Stefania Bezzio; Anna Pegoraro; Franco Aversa; Simone Cesaro
Journal:  Pediatr Rep       Date:  2011-02-24

8.  Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010?

Authors:  Elio Castagnola; Ilaria Caviglia; Riccardo Haupt
Journal:  Pediatr Rep       Date:  2011-02-24

Review 9.  Adoptive T-cell therapy for fungal infections in haematology patients.

Authors:  Shivashni S Deo; David J Gottlieb
Journal:  Clin Transl Immunology       Date:  2015-08-14

10.  Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy.

Authors:  Özlem Tüfekçi; Şebnem Yılmaz Bengoa; Fatma Demir Yenigürbüz; Erdem Şimşek; Tuba Hilkay Karapınar; Gülersu İrken; Hale Ören
Journal:  Turk J Haematol       Date:  2015-04-27       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.